Recruiting
Phase 2

BElumosudil

Sponsor:

Dana-Farber Cancer Institute

Code:

NCT05922761

Conditions

Bronchiolitis Obliterans Syndrome

Bronchiolitis Obliterans

Lung Diseases

Chronic Graft Versus Host Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Belumosudil

Fluticasone

Azithromycin

Prednisone

Montelukast

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2025-06-05.